The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial.
JMIR Res Protoc
; 11(10): e37452, 2022 Oct 11.
Article
in En
| MEDLINE
| ID: mdl-36222789
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Prognostic_studies
Language:
En
Journal:
JMIR Res Protoc
Year:
2022
Document type:
Article
Affiliation country:
Spain
Country of publication:
Canada